z-logo
open-access-imgOpen Access
Vaccine nationalism and the dynamics and control of SARS-CoV-2
Author(s) -
Caroline E. Wagner,
Chadi M. Saad-Roy,
Sinead E. Morris,
Rachel E. Baker,
Michael J. Mina,
Jeremy Farrar,
Edward C. Holmes,
Oliver G. Pybus,
Andrea L. Graham,
Ezekiel Emanuel,
Simon A. Levin,
C. Jessica E. Metcalf,
Bryan T. Grenfell
Publication year - 2021
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.abj7364
Subject(s) - covid-19 , nationalism , virology , dynamics (music) , betacoronavirus , control (management) , coronavirus infections , political science , biology , medicine , sociology , computer science , outbreak , law , infectious disease (medical specialty) , politics , artificial intelligence , disease , pathology , pedagogy
Stockpiling and control A triumph that has emerged from the catastrophe of the severe acute respiratory syndrome coronavirus 2 pandemic has been the rapid development of several potent vaccines. However, 18 months into the pandemic and more than 6 months after vaccine approval, wealthy countries remain the major beneficiaries. Wagneret al . model the consequences of vaccine stockpiling in affluent countries on disease rates in lower- and middle-income countries and the consequences for the eruption of new variants that could jeopardize the early success of vaccines. For countries that can readily access vaccines, it would be better to share vaccines equitably to lower disease burdens in countries with less access, reduce the cost of having to be constantly vigilant for case imports, and minimize virus evolution. —CA

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom